Cadrenal Therapeutics Inc —— 资产负债表 (NASDAQ:CVKD)

Financials

总资产 778.17 K8.52 M10.12 M4.33 M 负债总额 6.33 M826.88 K2.68 M1.59 M 权益总额 -5.55 M7.69 M7.44 M2.74 M 负债及股东权益总额 778.17 K8.52 M10.12 M4.33 M 总债务 1.15 M0—— 净债务 1.12 M-8.4 M——

新闻

Cadrenal schedules FDA meeting for HIT drug CAD-1005

Cadrenal Therapeutics股价因二期临床试验结果大涨

Cadrenal Therapeutics stock surges on Phase 2 trial results

Cadrenal的CAD-1005在HIT试验中显示血栓减少

Cadrenal’s CAD-1005 shows reduction in blood clots in HIT trial

Cadrenal强调12-LOX抑制剂对血液疾病的潜力

Cadrenal highlights potential of 12-LOX inhibitor for blood disorder

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics首席财务官Szot出售价值1496美元股票